Rezultati - James Markowitz
- Showing 1 - 20 results of 46
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Transition of the Patient With Inflammatory Bowel Disease From Pediatric to Adult Care: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and... od Robert N. Baldassano, George D. Ferry, Anne Griffiths, David R. Mack, James Markowitz, Harland S. Winter
Izdano 2002Artigo -
6
-
7
Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease od James Markowitz, Jeffrey S. Hyams, David Mack, Neal S. LeLeiko, Jonathan Evans, Subra Kugathasan, Marian Pfefferkorn, Adam Mezoff, Joel R. Rosh, Vasundhara Tolia
Izdano 2006Artigo -
8
-
9
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis od Eytan Wine, David R. Mack, Jeffrey S. Hyams, Anthony Otley, James Markowitz, Wallace Crandall, Neal S. LeLeiko, Aleixo M. Muise, Anne M. Griffiths, Dan Turner
Izdano 2013Artigo -
10
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis od Dan Turner, David Mack, Jeffrey S. Hyams, Neal S. LeLeiko, Anthony Otley, James Markowitz, Yair Kasirer, Aleixo M. Muise, Cynthia H. Seow, Mark S. Silverberg, Wallace Crandall, Anne M. Griffiths
Izdano 2011Artigo -
11
Pediatric modification of the Montreal classification for inflammatory bowel disease od Arie Levine, Anne M. Griffiths, James Markowitz, David C. Wilson, Dan Turner, Richard K. Russell, John Fell, Frank M. Ruemmele, Thomas D. Walters, Mary Sherlock, Marla Dubinsky, Jeffrey S. Hyams
Izdano 2010Artigo -
12
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the <scp>VedoKids</scp> Prospective Multicentre Study od Ronen Stein, Dan Turner, Séamus Hussey, Aysha Kawasmi, Oren Ledder, Jeremiah Levine, James Markowitz, Manar Matar, E Orlanski-Meyer, Richard K. Russell, Ron Shaoul, Anat Yerushalmy‐Feler, Diane R. Mould, Máire Conrad
Izdano 2025Artigo -
13
Infliximab Therapy in Children With Concurrent Perianal Crohn Disease: Observations From REACH od Wallace Crandall, Jeffrey S. Hyams, Subra Kugathasan, Anne M. Griffiths, Julie Zrubek, Allan Olson, Grace Liu, Robert Heuschkel, James Markowitz, Stanley A. Cohen, Harland S. Winter, G. Veereman‐Wauters, George D. Ferry, Robert N. Baldassano
Izdano 2009Artigo -
14
Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children od Jeffrey S. Hyams, Anne M. Griffiths, James Markowitz, Robert N. Baldassano, William A. Faubion, Richard B. Colletti, Marla Dubinsky, Jarosław Kierkuś, Joel R. Rosh, Yaqin Wang, Bidan Huang, Barry Bittle, Michael Marshall, Andreas Lazar
Izdano 2012Artigo -
15
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children od Jeffrey S. Hyams, Wallace Crandall, Subra Kugathasan, Anne M. Griffiths, Allan Olson, Jewel Johanns, Grace Liu, Suzanne Travers, Robert Heuschkel, James Markowitz, Stanley A. Cohen, Harland S. Winter, G. Veereman‐Wauters, George D. Ferry, Robert N. Baldassano
Izdano 2006Artigo -
16
Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen od Sanam Soomro, Suresh Venkateswaran, Kamala Vanarsa, Marwa Kharboutli, Malavika Nidhi, Ramya Susarla, Ting Zhang, Prashanth Sasidharan, Kyung Hyun Lee, Joel R. Rosh, James Markowitz, Claudia Pedroza, Lee A. Denson, Jeffrey S. Hyams, Subra Kugathasan, Chandra Mohan
Izdano 2021Artigo -
17
Intercenter variation in initial management of children with Crohnʼs disease od Michael D. Kappelman, Athos Bousvaros, Jeffrey S. Hyams, James Markowitz, Marian Pfefferkorn, Subra Kugathasan, Joel R. Rosh, Anthony Otley, David Mack, Anne M. Griffiths, Jonathan Evans, Richard J. Grand, Christine R. Langton, Ken Kleinman, Jonathan A. Finkelstein
Izdano 2007Artigo -
18
Severe Pediatric Ulcerative Colitis: A Prospective Multicenter Study of Outcomes and Predictors of Response od Dan Turner, David R. Mack, Neal S. LeLeiko, Thomas D. Walters, Krista Uusoue, Steven T. Leach, Andrew S. Day, Wallace Crandall, Mark S. Silverberg, James Markowitz, Anthony Otley, David J. Keljo, Petar Mamula, Subra Kugathasan, Jeffrey S. Hyams, Anne M. Griffiths
Izdano 2010Artigo -
19
Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease od Jeffrey S. Hyams, Trudy Lerer, Anne M. Griffiths, Marian Pfefferkorn, Subra Kugathasan, Jonathan Evans, Anthony Otley, Ryan Carvalho, David Mack, Athos Bousvaros, Joel R. Rosh, Petar Mamula, Marsha Kay, Wallace Crandall, Maria Oliva‐Hemker, David J. Keljo, Neal S. LeLeiko, James Markowitz
Izdano 2008Artigo -
20
Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms od Marian Pfefferkorn, Georgine Burke, Anne M. Griffiths, James Markowitz, Joel R. Rosh, David Mack, Anthony Otley, Subra Kugathasan, Jonathan Evans, Athos Bousvaros, M. Susan Moyer, Robert Wyllie, Maria Oliva‐Hemker, Ryan Carvalho, Wallace Crandall, David J. Keljo, TD Walters, Neal S. LeLeiko, Jeffrey S. Hyams
Izdano 2009Artigo
Iskalna orodja:
Sorodne teme
Medicine
Disease
Internal medicine
Inflammatory bowel disease
Crohn's disease
Gastroenterology
Ulcerative colitis
Immunology
Infliximab
Biology
Pediatrics
Cohort
Gene
Genetics
Confidence interval
Prospective cohort study
Surgery
Gene expression
Bioinformatics
Pathology
Cohort study
Colectomy
Corticosteroid
Inflammation
Microbiome
Pathogenesis
Pediatric gastroenterology
Chemotherapy
Computational biology
Crohn disease